#

Freedom Holding

: 459
A company that makes money by leasing oil and gas lands it controls for use has gone public / Photo: unsplash.com / Brad Weaver
News·
EagleRock Land IPO: Oil royalty landowner goes public
The convergence of AI, cloud computing, and broader economic digitalization is driving unprecedented demand for data centers globally, the company argued in its prospectus / Photo: Unsplash / Geoffrey Moffett
Small Caps·
+1
·
Blackstone Digital Infrastructure IPO: Data center REIT debuts on NYSE
Fervo uses horizontal drilling and multi-stage hydraulic fracturing to produce geothermal energy and expects to deliver power at its first commercial station by the end of 2026 / Photo: Fervo Energy
News·
+1
·
Fervo Energy IPO: Geothermal energy developer debuts on the Nasdaq
GMR specializes in emergency medical care / Photo: GMR
News·
GMR IPO: emergency ambulance service provider goes public
Founded in 2021, Odyssey is developing therapies to treat patients with autoimmune diseases like ulcerative colitis, Crohn’s disease, and lupus / Photo: Odyssey Therapeutics
Small Caps·
Odyssey IPO: Immune system biotech debuts on the Nasdaq
Mobia Medicals development - Vivistim device for vagus nerve stimulation / Photo: Vivistim.com
News·
Mobia Medical IPO: developer of stroke rehabilitation systems goes public
HawkEye 360, a provider of satellite-based signals intelligence for U.S. government agencies, has gone public in a deal priced at the top of the marketed range / Photo: X / HawkEye 360
Small Caps·
HawkEye 360 IPO: Surveillance firm debuts on the NYSE
Suja Life plans to use the proceeds from the share placement for brand marketing / Photo: Suja Life
News·
Suja Life IPO: shares in the juice maker have become available. It is a competitor of Coca-Cola
Spains financial sector is likely to remain strong, but the growth driver is gradually shifting / Photo: Pedro Santa Cruz personal archive
Review·
"The utilities sector is a key defensive segment": an interview with the head of Freedom24 in Spain
Hemab is developing therapies for blood coagulation disorders such as Glanzmann thrombasthenia and Von Willebrand Disease, according to its filings / Photo: Hemab Therapeutics
Small Caps·
+1
·
Hemab IPO: Novo-backed blood disorder biotech debuts on the Nasdaq
Seaport Therapeutics shares become available / Photo: Seaport Therapeutics
News·
IPO of Seaport Therapeutics: shares of the antidepressant developer become available
Boston-based biotech Avalyn Pharma develops inhaled drugs / Photo: Avalyn Pharma
News·
Avalyn Pharma IPO: Novo Nordisk-backed biotech goes public
Load more